Open innovation is embedded in our organisation. Our industrial pharma capabilities have been recognized by the European Community who has chosen us as the central screening site for the European Lead factory.

Pivot Park Screening Centre is also partner in several other collaboration projects, all based on open innovation.


COILED (Center of Open Innovation for Lead Discovery) is a collaborative drug discovery initiative. COILED amalgamates leading academic biomedical research with industry-standard medicinal chemistry to accelerate and valorize innovation.

Radboud University, RadboudUMC, Inntrest Consultancy, Pivot Park Screeening Centre and BioAxis Research have built an unique drug discovery program to deliver next generation of immuno modulatory drugs to combat disease with an unmet medical need.

Radboud University

TKI Oncodrugs

This project aims for finding potential active compounds that could be further developed into oncological drugs. By bringing together the practical expertise and knowledge of several partners, it is expected that new leads for candidate medicines will be found in a lesser amount of time.

Universiteit Leiden
Lead Pharma

Cancer Drug Discovery Initiative

It is CDDI’s ambition to discover two lead series with the potential of becoming a candidate medicine in a period of three years’ time. The partner’s knowledge and techniques will be combined to reach this objective. Anti-cancer targets re being selected by the Dutch Cancer Institute (AVL) and are screened by the Pivot Park Screening Centre. Leiden University is responsible for the medicinal chemistry and safety and efficacy testing.

Universiteit Leiden